At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
AMLX Amylyx Pharmaceuticals
Pre-Mkt 09-11 08:26:33 EDT
32.09
-0.31
-0.96%
盘前32.42
+0.33+1.03%
07:52 EDT
High32.57Low31.44Vol1.78M
Open31.81D1 Closing32.40Amplitude3.49%
Mkt Cap4.03BTradable Cap3.51BTotal Shares125.46M
T/O57.09MT/O Rate1.62%Tradable Shares109.51M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Brent Crude Surges Past $102 as Escalating U.S.-Iran Conflict Drives Energy Inflation Concerns
TIPRANKS  ·  09-10 19:04
Brent Crude Surges Past $102 as Escalating U.S.-Iran Conflict Drives Energy Inflation Concerns
Amylyx inks long-term manufacturing deal for avexitide
TIPRANKS  ·  09-09 05:18
Amylyx inks long-term manufacturing deal for avexitide
Amylyx Pharmaceuticals - Bachem and Polypeptide to be Non-Exclusive Suppliers for Amylyx - SEC Filing
THOMSON REUTERS  ·  09-09 04:55
Amylyx Pharmaceuticals - Bachem and Polypeptide to be Non-Exclusive Suppliers for Amylyx - SEC Filing
Amylyx Pharmaceuticals - Polypeptide Agreement Includes Fixed Volume-Based Pricing with Annual Adjustment - SEC Filing
THOMSON REUTERS  ·  09-09 04:55
Amylyx Pharmaceuticals - Polypeptide Agreement Includes Fixed Volume-Based Pricing with Annual Adjustment - SEC Filing
Amylyx Pharmaceuticals - Bachem Manufacturing Agreement Has Initial 5 Year Term, Auto-Renews for 3 Years, Unless Earlier Terminated with Its Terms
THOMSON REUTERS  ·  09-09 04:55
Amylyx Pharmaceuticals - Bachem Manufacturing Agreement Has Initial 5 Year Term, Auto-Renews for 3 Years, Unless Earlier Terminated with Its Terms
Amylyx Pharmaceuticals - Enters Manufacturing Agreement with Bachem Americas on Sept 8, 2026 - SEC Filing
THOMSON REUTERS  ·  09-09 04:55
Amylyx Pharmaceuticals - Enters Manufacturing Agreement with Bachem Americas on Sept 8, 2026 - SEC Filing
Amylyx Signs Bachem Manufacturing Deal for Avexitide Supply Starting 2028
Reuters  ·  09-09 04:55
Amylyx Signs Bachem Manufacturing Deal for Avexitide Supply Starting 2028
Amylyx Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference
Reuters  ·  09-08 21:00
Amylyx Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference
Hedge Fund Giant Sets Sights on US Shale Assets After Missing Out on WildFire Deal
Deep News  ·  09-05
Hedge Fund Giant Sets Sights on US Shale Assets After Missing Out on WildFire Deal
Is Amylyx Pharmaceuticals (AMLX) Expensive As Phase 3 Avexitide Data Clears The Way?
Simply Wall St.  ·  09-01
Is Amylyx Pharmaceuticals (AMLX) Expensive As Phase 3 Avexitide Data Clears The Way?
Amylyx Pharmaceuticals is Maintained at Buy by Guggenheim
Dow Jones  ·  08-27
Amylyx Pharmaceuticals is Maintained at Buy by Guggenheim
BW Offshore Shares Trade Ex-Dividend Ahead of Early September Payout
TIPRANKS  ·  08-27
BW Offshore Shares Trade Ex-Dividend Ahead of Early September Payout
Williams named Top Pick in midstream energy infrastructure at Morgan Stanley
TIPRANKS  ·  08-26
Williams named Top Pick in midstream energy infrastructure at Morgan Stanley
NU E Power Corp. Bolsters Operational Leadership With New COO
TIPRANKS  ·  08-26
NU E Power Corp. Bolsters Operational Leadership With New COO
Ansaldo Energia selects Kinaxis to power global energy infrastructure
TIPRANKS  ·  08-25
Ansaldo Energia selects Kinaxis to power global energy infrastructure
Oracle Stock Leads This High Growth Watchlist For 2026
Simply Wall St.  ·  08-23
Oracle Stock Leads This High Growth Watchlist For 2026
ETF Weekly | ETHU Jumps 62%; NUGT Climbs 29%; SMST, MSTZ Sink 45%; Crypto Leverage Sets the Pace
ETF Weekly  ·  08-23
ETF Weekly | ETHU Jumps 62%; NUGT Climbs 29%; SMST, MSTZ Sink 45%; Crypto Leverage Sets the Pace
Amylyx Pharmaceuticals Inc (AMLX) Gets a Buy from LifeSci Capital
TIPRANKS  ·  08-23
Amylyx Pharmaceuticals Inc (AMLX) Gets a Buy from LifeSci Capital
Amylyx Pharmaceuticals Announces Equity Offering to Fund Avexitide
TIPRANKS  ·  08-21
Amylyx Pharmaceuticals Announces Equity Offering to Fund Avexitide
Chevron Stock (CVX) Breaks Past $196 Resistance as Strong Crude Prices Fuel Growth
TIPRANKS  ·  08-21
Chevron Stock (CVX) Breaks Past $196 Resistance as Strong Crude Prices Fuel Growth

Introduction

Company Name.
Amylyx Pharmaceuticals
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Amylyx Pharmaceuticals, Inc., a commercial-stage biotechnology company, engages in the discovery and development of treatment for amyotrophic lateral sclerosis (ALS) and neurodegenerative diseases. The company's products include RELYVRIO, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment of ALS in adults in the United States and marketed as ALBRIOZA for the treatment of ALS in Canada. It is also developing AMX0114 for other neurodegenerative diseases. Amylyx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.
Issue price:
--